Fresenius SE & Co. (OTCMKTS:FSNUY) Announces Quarterly Earnings Results

Fresenius SE & Co. (OTCMKTS:FSNUY) released its quarterly earnings data on Wednesday. The company reported $0.28 earnings per share for the quarter, Zacks reports. Fresenius SE & Co. had a return on equity of 9.72% and a net margin of 5.26%.

Fresenius SE & Co. Stock Up 1.4%

FSNUY traded up $0.21 on Wednesday, hitting $15.21. The company had a trading volume of 2,645 shares, compared to its average volume of 54,765. The stock has a fifty day simple moving average of $14.53 and a 200-day simple moving average of $14.39. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.26 and a quick ratio of 0.99. The firm has a market capitalization of $34.27 billion, a P/E ratio of 27.65 and a beta of 0.75. Fresenius SE & Co. has a 52-week low of $9.78 and a 52-week high of $33.93.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, December 15th. Citigroup reaffirmed a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has an average rating of “Buy”.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.